Heidelberg- Start of a new trial site

Today, the University Hopsital Heidelberg became officially an active trial site of the STOP-PKD Study.

The team of Prof. Claudia Sommerer cares for patients with a wide range of nephrological issues, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

Interested patients can now make an appointment at the trial site in Heidelberg to obtain detailed information about the trial and potential participation.

Phone: +49622156251449

Email: Studienzentrum-Nephrologie.MED10@med.uni-heidelberg.de